Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Renal Failure

  Free Subscription

Articles published in Ren Fail

Retrieve available abstracts of 106 articles:
HTML format

Single Articles

    December 2022
  1. MATSUMOTO J, Saka Y, Mimura T, Naruse T, et al
    Duration of SARS-CoV-2 antigen positivity in hemodialysis patients.
    Ren Fail. 2022;44:11-13.

  2. ANAPALLI SR, N HD, Sarma P, Srikanth L, et al
    Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience.
    Ren Fail. 2022;44:34-42.
    PubMed     Abstract available

  3. SU C, Wang T, Wang P, Lu X, et al
    The estimation of protein equivalents of total nitrogen in Chinese CAPD patients: an explanatory study.
    Ren Fail. 2022;44:14-22.
    PubMed     Abstract available

  4. SHI H, Su X, Yan B, Li C, et al
    Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis.
    Ren Fail. 2022;44:106-115.
    PubMed     Abstract available

  5. MISIAN M, Baum E, Breborowicz A
    Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.
    Ren Fail. 2022;44:54-61.
    PubMed     Abstract available

  6. HE S, Xiong Q, Li L, Lin X, et al
    Increased risk of modality failure with higher serum uric acid level in continuous ambulatory peritoneal dialysis patients: a prospective cohort study.
    Ren Fail. 2022;44:272-281.
    PubMed     Abstract available

  7. LIU Y, Ma Z, Huang Z, Zou D, et al
    MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/beta-catenin pathway.
    Ren Fail. 2022;44:191-203.
    PubMed     Abstract available

  8. JIN L, Wang X, Ma Y, Zheng J, et al
    Serum albumin at 1 year after peritoneal dialysis predicts long-term outcomes on continuous ambulatory peritoneal dialysis.
    Ren Fail. 2022;44:252-257.
    PubMed     Abstract available

  9. ELLIOTT AB, Soliman KMM, Ullian ME
    Hyperkalemia in chronic peritoneal dialysis patients.
    Ren Fail. 2022;44:217-223.
    PubMed     Abstract available

  10. XIONG JQ, Chen XM, Liang CT, Guo W, et al
    Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration.
    Ren Fail. 2022;44:224-232.
    PubMed     Abstract available

  11. LUO C, Liang M, Liu Y, Zheng D, et al
    Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials.
    Ren Fail. 2022;44:155-170.
    PubMed     Abstract available

  12. TAO M, Zheng D, Liang X, He Q, et al
    Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.
    Ren Fail. 2022;44:81-93.
    PubMed     Abstract available

  13. ZHANG T, Zhu Z, Yang H, Cao S, et al
    Association between red blood cell distribution width and non-valvular atrial fibrillation in hemodialysis patients: a single-center Chinese population study.
    Ren Fail. 2022;44:62-69.
    PubMed     Abstract available

  14. XUE C, Liang C, Zhang L, Zhou C, et al
    A program for early detection and management of chronic kidney disease.
    Ren Fail. 2022;44:250-251.

  15. ZUO Q, Wang T, Zhu L, Li X, et al
    A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients.
    Ren Fail. 2022;44:94-102.
    PubMed     Abstract available

  16. ZHAO L, Han Q, Zhou L, Bai L, et al
    Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes.
    Ren Fail. 2022;44:346-357.
    PubMed     Abstract available

  17. WANG C, Chen C, Wang J, Guo X, et al
    Delayed gastric emptying in nondiabetic patients with end-stage kidney disease.
    Ren Fail. 2022;44:329-335.
    PubMed     Abstract available

  18. ZENG Y, Liu L, Zhu L, Zhan X, et al
    Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients.
    Ren Fail. 2022;44:407-414.
    PubMed     Abstract available

  19. TSUJI K, Kitamura M, Chiba K, Muta K, et al
    Comparison of bone microstructures via high-resolution peripheral quantitative computed tomography in patients with different stages of chronic kidney disease before and after starting hemodialysis.
    Ren Fail. 2022;44:381-391.
    PubMed     Abstract available

  20. PARSHINA E, Zulkarnaev A, Tolkach A, Ivanov A, et al
    Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study.
    Ren Fail. 2022;44:392-398.
    PubMed     Abstract available

  21. WEN X, Yang L, Sun Z, Zhang X, et al
    Feasibility of a break-in period of less than 24 hours for urgent start peritoneal dialysis: a multicenter study.
    Ren Fail. 2022;44:450-460.
    PubMed     Abstract available

  22. ZHANG X, Xu W, Huang T, Huang J, et al
    The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.
    Ren Fail. 2022;44:146-154.
    PubMed     Abstract available

  23. CHEN J, Zheng B, Yin L, Zhou Q, et al
    Exploring agreement and feasibility between virtual home visits and in-person home visits for peritoneal dialysis patients-a paired study.
    Ren Fail. 2022;44:490-502.
    PubMed     Abstract available

  24. LIU S, Zhang L, Ma S, Xiao J, et al
    Kt/V reach rate is associated with clinical outcome in incident peritoneal dialysis patients.
    Ren Fail. 2022;44:482-489.
    PubMed     Abstract available

  25. GAO D, Lou Y, Cui Y, Liu S, et al
    Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis.
    Ren Fail. 2022;44:503-512.
    PubMed     Abstract available

  26. WU T, Qi Y, Ma S, Zhang L, et al
    Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis.
    Ren Fail. 2022;44:529-540.
    PubMed     Abstract available

  27. ZHAO Y, Gan L, Niu Q, Ni M, et al
    Efficacy and safety of expanded hemodialysis in hemodialysis patients: a meta-analysis and systematic review.
    Ren Fail. 2022;44:541-550.
    PubMed     Abstract available

  28. CHEN L, Tang X, Zheng H, Wang H, et al
    Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study.
    Ren Fail. 2022;44:336-345.
    PubMed     Abstract available

  29. ZOU Y, Zhao L, Zhang J, Wang Y, et al
    Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Ren Fail. 2022;44:562-570.
    PubMed     Abstract available

  30. WANG M, Lin X, Yang X, Yang Y, et al
    Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease.
    Ren Fail. 2022;44:615-624.
    PubMed     Abstract available

  31. TING SW, Chen JJ, Lee TH, Kuo G, et al
    Surgical versus medical treatment for infective endocarditis in patients on dialysis: a systematic review and meta-analysis.
    Ren Fail. 2022;44:706-713.
    PubMed     Abstract available

  32. ZHAO Y, Wang W, Zhilong D
    What is the real predictor of coronary artery calcification in patients with chronic kidney disease?
    Ren Fail. 2022;44:269-271.

  33. BAI Q, Tang W
    Artificial intelligence in peritoneal dialysis: general overview.
    Ren Fail. 2022;44:682-687.
    PubMed     Abstract available

  34. GORAYEB-POLACCHINI FS, Caldas HC, Abbud-Filho M
    The severity of the second wave of SARS CoV-2 in maintenance dialysis patients of a single center in Brazil.
    Ren Fail. 2022;44:748-751.

  35. YI C, Ye H, Lin J, Chang Y, et al
    The incidence of pain and its association with quality of life in patients with peritoneal dialysis.
    Ren Fail. 2022;44:724-730.
    PubMed     Abstract available

  36. XIAO Q, Tang Y, Xia J, Luo H, et al
    Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.
    Ren Fail. 2022;44:752-766.
    PubMed     Abstract available

  37. LIU X, Du H, Sun Y, Shao L, et al
    Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention.
    Ren Fail. 2022;44:790-805.
    PubMed     Abstract available

  38. MENG Y, Wu HT, Niu JL, Zhang Y, et al
    Prevalence of depression and anxiety and their predictors among patients undergoing maintenance hemodialysis in Northern China: a cross-sectional study.
    Ren Fail. 2022;44:933-944.
    PubMed     Abstract available

  39. MIAO C, Zhu X, Wei X, Long M, et al
    Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.
    Ren Fail. 2022;44:881-892.
    PubMed     Abstract available

  40. XIAO L, Ran X, Zhong Y, Le Y, et al
    Serum creatine kinase levels are not associated with an increased need for continuous renal replacement therapy in patients with acute kidney injury following rhabdomyolysis.
    Ren Fail. 2022;44:893-901.
    PubMed     Abstract available

  41. PETHO A, Szebeni J
    Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes?
    Ren Fail. 2022;44:693.

  42. MILKOWSKI A, Prystacki T, Marcinkowski W, Dryl-Rydzynska T, et al
    Lack or insufficient predialysis nephrology care worsens the outcomes in dialyzed patients - call for action.
    Ren Fail. 2022;44:946-957.
    PubMed     Abstract available

  43. MASUYAMA S, Mizui M, Maeda K, Shimamura K, et al
    Preoperative hypomagnesemia as a possible predictive factor for postoperative increase of transvalvular pressure gradient in hemodialysis patients treated with transcatheter aortic valve implantation.
    Ren Fail. 2022;44:1083-1089.
    PubMed     Abstract available

  44. WIELICZKO M, Malyszko J
    Acid-base balance in hemodialysis patients in everyday practice.
    Ren Fail. 2022;44:1090-1097.
    PubMed     Abstract available

  45. IKEDA N, Hayashi T, Gen S, Joki N, et al
    Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Ren Fail. 2022;44:1098-1103.
    PubMed     Abstract available

  46. LIN YL, Lin CY, Liu JH
    Vaccine-induced immune thrombotic thrombocytopenia presenting as a mimic of heparin-induced thrombocytopenia in a hemodialysis patient receiving ChAdOx1 nCoV-19 vaccine.
    Ren Fail. 2022;44:1130-1133.

  47. YAN C, Zeng C, Ma Y, Zhan X, et al
    Prevalence and risk factors of poor sleep quality in continuous ambulatory peritoneal dialysis patients in Nanchang, Southeast China.
    Ren Fail. 2022;44:1144-1149.
    PubMed     Abstract available

  48. CHENG L, Chang L, Tian R, Zhou J, et al
    The predictive value of bioimpedance-derived fluid parameters for cardiovascular events in patients undergoing hemodialysis.
    Ren Fail. 2022;44:1192-1200.
    PubMed     Abstract available

  49. LI J, Li Y, Zou Y, Chen Y, et al
    Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis.
    Ren Fail. 2022;44:1227-1235.
    PubMed     Abstract available

  50. HUANG QX, Pang J, Shi CK, Huang XW, et al
    Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism.
    Ren Fail. 2022;44:1160-1168.
    PubMed     Abstract available

  51. HUANG J, Gu A, Li N, He Y, et al
    Self-care or assisted PD: development of a new approach to evaluate manual peritoneal dialysis practice ability.
    Ren Fail. 2022;44:1319-1325.
    PubMed     Abstract available

  52. BOUAZZA A, Tahar A, AitAbderrhmane S, Saidani M, et al
    Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D3 supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities.
    Ren Fail. 2022;44:1243-1262.
    PubMed     Abstract available

  53. LI L, Zheng X, Deng J, Zhou J, et al
    Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials.
    Ren Fail. 2022;44:1112-1122.
    PubMed     Abstract available

  54. RIOS P, Silvarino R, Sola L, Ferreiro A, et al
    Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort.
    Ren Fail. 2022;44:1356-1367.
    PubMed     Abstract available

  55. CHEN S, Chen L, Jiang H
    Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Ren Fail. 2022;44:1309-1318.
    PubMed     Abstract available

  56. LEE TW, Bae W, Choi J, Bae E, et al
    The neutrophil-to-lymphocyte ratio may indicate when to start hemodialysis.
    Ren Fail. 2022;44:1401-1408.
    PubMed     Abstract available

  57. HE J, Sun X, Nie R, Zhao L, et al
    Relationship between serum parathyroid hormone levels and abdominal aortic calcification in patients starting hemodialysis who have never taken calcium tablets, calcitriol, or vitamin D analogs.
    Ren Fail. 2022;44:1409-1416.
    PubMed     Abstract available

  58. XIAO X, Ren H, Gao P, Yin D, et al
    What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
    Ren Fail. 2022;44:1477-1485.
    PubMed     Abstract available

  59. XIAO Q, Tang Y, Luo H, Chen S, et al
    Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling.
    Ren Fail. 2022;44:1426-1442.
    PubMed     Abstract available

  60. WANG Y, Sun X
    Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Ren Fail. 2022;44:1501-1518.
    PubMed     Abstract available

  61. LI F, Wang L, Mao Y, Mao C, et al
    Established risk prediction models for the incidence of a low lean tissue index in patients with peritoneal dialysis.
    Ren Fail. 2022;44:1417-1425.
    PubMed     Abstract available

  62. WU J, Li J, Feng B, Bi Z, et al
    Activation of AMPK-PGC-1alpha pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis.
    Ren Fail. 2022;44:1545-1557.
    PubMed     Abstract available

  63. HUANG DD, Li YY, Qi XM, Wu YG, et al
    A nomogram predicts cardiovascular events in patients with peritoneal dialysis-associated peritonitis.
    Ren Fail. 2022;44:1558-1567.
    PubMed     Abstract available

  64. ZHANG Y, Li J, Chen Z, Liu L, et al
    Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients.
    Ren Fail. 2022;44:1623-1631.
    PubMed     Abstract available

  65. CHEN R, Zhang L, Zhang M, Wang Y, et al
    The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis.
    Ren Fail. 2022;44:1615-1621.
    PubMed     Abstract available

  66. CHEN MY, Ou SH, Chen NC, Yin CH, et al
    Aluminum overload in the reverse osmosis dialysis era: does it exist?
    Ren Fail. 2022;44:1595-1603.
    PubMed     Abstract available

  67. FU C, Zhang D, Chen H, Zhang H, et al
    Timed-averaged blood pressure showed a J-curve association with stroke in elderly chronic kidney disease patients.
    Ren Fail. 2022;44:1677-1686.
    PubMed     Abstract available

  68. HU C, Zhang Y, Bi X, Yao L, et al
    Correlation between serum trimethylamine-N-oxide concentration and protein energy wasting in patients on maintenance hemodialysis.
    Ren Fail. 2022;44:1669-1676.
    PubMed     Abstract available

  69. SZENTIMREI R, Lorincz H, Szentpeteri A, E Varga V, et al
    Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease.
    Ren Fail. 2022;44:1649-1659.
    PubMed     Abstract available

  70. DOU Y, Gong Y, Li A, Wang P, et al
    A comparison of fluid status determination using bioelectric impedance and the isotope dilution method in hemodialysis and peritoneal dialysis patients.
    Ren Fail. 2022;44:1698-1707.
    PubMed     Abstract available

  71. HUANG Q, Li J, Huang N, Xia X, et al
    Clinical characteristics and outcomes of antibiotic-associated encephalopathy in patients with end-stage kidney disease.
    Ren Fail. 2022;44:1708-1716.
    PubMed     Abstract available

  72. TIAN R, Chang L, Liu D, Luo F, et al
    Association of the modified creatinine index with muscle strength and mortality in patients undergoing hemodialysis.
    Ren Fail. 2022;44:1732-1742.
    PubMed     Abstract available

  73. LI X, Bai M, Yu Y, Ma F, et al
    Earlier continuous renal replacement therapy is associated with reduced mortality in rhabdomyolysis patients.
    Ren Fail. 2022;44:1743-1753.
    PubMed     Abstract available

  74. KOBAYASHI S, Tanaka K, Hoshino J, Hara S, et al
    Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis.
    Ren Fail. 2022;44:1801-1810.
    PubMed     Abstract available

  75. LIANG Y, Gan L, Shen Y, Li W, et al
    Clinical characteristics and management of hemodialysis patients with pre-dialysis hypertension: a multicenter observational study.
    Ren Fail. 2022;44:1811-1818.
    PubMed     Abstract available

  76. SU N, Tang X, Zhan X, Wang X, et al
    The relationship between platelet distribution width and new-onset cardiovascular disease events in patients with peritoneal dialysis.
    Ren Fail. 2022;44:1640-1648.
    PubMed     Abstract available

  77. CHEN Z, Xu J, Xing X, Xue C, et al
    p-Cresyl sulfate predicts clinical outcomes in sustained peritoneal dialysis: a 5-year follow-up cohort study and meta-analysis.
    Ren Fail. 2022;44:1791-1800.
    PubMed     Abstract available

  78. KALOUSOVA M, Zelenkova M, Kubena AA, Dusilova-Sulkova S, et al
    Retinoic acid associates with mortality of patients on long-term hemodialysis.
    Ren Fail. 2022;44:1866-1872.
    PubMed     Abstract available

  79. HE L, Yang W, Yang P, Zhang X, et al
    Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients.
    Ren Fail. 2022;44:2019-2027.
    PubMed     Abstract available

  80. HU Q, Chen Y, Bao T, Huang Y, et al
    Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
    Ren Fail. 2022;44:1996-2005.
    PubMed     Abstract available

  81. XIE J, Ma X, Zheng Y, Mao N, et al
    Panax notoginseng saponins alleviate damage to the intestinal barrier and regulate levels of intestinal microbes in a rat model of chronic kidney disease.
    Ren Fail. 2022;44:1948-1960.
    PubMed     Abstract available

  82. WANG XP, Ma Y, Lv J, Liang Y, et al
    Influence of dietary protein on serum phosphorous levels in peritoneal dialysis patients with different initial transport function.
    Ren Fail. 2022;44:2085-2092.
    PubMed     Abstract available

  83. JIN Y, Huang X, Zhang C, Xie J, et al
    Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis.
    Ren Fail. 2022;44:2066-2072.
    PubMed     Abstract available

  84. LIU Y, Chang WX, Cheng BC, Chen JB, et al
    Is regular in-person recall superior to non-regular in-person recall in clinical outcomes among new patients undergoing peritoneal dialysis.
    Ren Fail. 2022;44:2010-2018.
    PubMed     Abstract available

    January 2022
  85. LI N, Zhou G, Zheng Y, Zhou E, et al
    Development and validation of a novel nomogram to predict overall survival of patients with moderate to severe chronic kidney disease.
    Ren Fail. 2022;44:241-249.
    PubMed     Abstract available

    December 2021
  86. YANG Y, Yuan J, Liu L, Qie S, et al
    Platelet-to-albumin ratio: a risk factor associated with technique failure and mortality in peritoneal dialysis patients.
    Ren Fail. 2021;43:1359-1367.
    PubMed     Abstract available

  87. SEVINC C, Yilmaz G, Ustundag S
    The relationship between calcification inhibitor levels in chronic kidney disease and the development of atherosclerosis.
    Ren Fail. 2021;43:1349-1358.
    PubMed     Abstract available

  88. ZHAO L, Liu A, Xu G
    Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis.
    Ren Fail. 2021;43:1378-1393.
    PubMed     Abstract available

  89. LIN SJ, Chang SC, Tung CW, Hsu YC, et al
    Timing of the first cannulation and survival of arteriovenous grafts in hemodialysis patients: a multicenter retrospective cohort study.
    Ren Fail. 2021;43:1416-1424.
    PubMed     Abstract available

  90. WANG F, Ao G, Wang Y, Liu F, et al
    Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis.
    Ren Fail. 2021;43:1394-1407.
    PubMed     Abstract available

  91. REN H, Zhao L, Zou Y, Wang Y, et al
    Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren Fail. 2021;43:477-487.
    PubMed     Abstract available

  92. SOSINSKA-ZAWIERUCHA P, Breborowicz A
    Uremic serum induces prothrombotic changes in venous endothelial cells and inflammatory changes in aortic endothelial cells.
    Ren Fail. 2021;43:401-405.
    PubMed     Abstract available

  93. YANG X, Zhao B, Wang J, Wang L, et al
    Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin.
    Ren Fail. 2021;43:1428-1436.
    PubMed     Abstract available

  94. DAOUD A, Ali H, Rao V, Rohan V, et al
    ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients.
    Ren Fail. 2021;43:1463-1464.

  95. YUAN D, Kuan T, Ling H, Wang H, et al
    Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis.
    Ren Fail. 2021;43:1479-1491.
    PubMed     Abstract available

  96. ZHANG L, Zhao Y, Guo Z, Ma J, et al
    Does serum calcium level play a practical role in calciphylaxis in hemodialysis patients?
    Ren Fail. 2021;43:1506-1507.

  97. RUAN L, Yao X, Li W, Zhang L, et al
    Effect of galectin-3 in the pathogenesis of arteriovenous fistula stenosis formation.
    Ren Fail. 2021;43:566-576.
    PubMed     Abstract available

  98. ZHOU S, Wang X, Shi J, Han Q, et al
    Serum fatty acid binding protein 4 levels are associated with abdominal aortic calcification in peritoneal dialysis patients.
    Ren Fail. 2021;43:1539-1548.
    PubMed     Abstract available

  99. KOSHI-ITO E, Inaguma D, Koide S, Takahashi K, et al
    Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis.
    Ren Fail. 2021;43:1528-1538.
    PubMed     Abstract available

  100. OUYANG H, Shi Q, Zhu J, Shen H, et al
    Nomogram for predicting 1-, 5-, and 10-year survival in hemodialysis (HD) patients: a single center retrospective study.
    Ren Fail. 2021;43:1508-1519.
    PubMed     Abstract available

  101. MOHAMED MM, Raja J, Ibrahim A, Raza H, et al
    Can restoration of heart rate in ESRD lower BNP? A case report.
    Ren Fail. 2021;43:1549-1550.

  102. BI SH, Chen W, Wu JS, Wang T, et al
    The history of peritoneal dialysis in China: past, present and future trends.
    Ren Fail. 2021;43:1601-1608.
    PubMed     Abstract available

  103. HU J, Zhang H, Yi B
    Peritoneal transport status and first episode of peritonitis: a large cohort study.
    Ren Fail. 2021;43:1094-1103.
    PubMed     Abstract available

  104. YE G, Yang W, Bi Z, Huang L, et al
    Effects of a high-phosphorus diet on the gut microbiota in CKD rats.
    Ren Fail. 2021;43:1577-1587.
    PubMed     Abstract available

  105. RACHOIN JS, Wolfe Y, Patel S, Cerceo E, et al
    Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?
    Ren Fail. 2021;43:1311-1321.
    PubMed     Abstract available

  106. KWON YE, Choi HM, Oh DJ
    Characteristics of bioimpedance-determined fluid shifts according to intradialytic blood pressure difference.
    Ren Fail. 2021;43:1446-1453.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.